February 2 – 4, 2024 | San Diego, CA
Activity Overview
The San Diego Dermatology Symposium (SDDS) seeks to educate healthcare professionals, who treat skin diseases, regarding emerging research and treatment updates for alopecia areata, acne, psoriasis, and skin cancer.
Target Audience
This conference has been designed for dermatologists, dermatology residents, primary care physicians, physicians, physician assistants and nurses involved in the care of patients with skin diseases
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Emphasize social, financial, and emotional burden associated with acne.
- Describe the mechanism of action and clinical evidence of emerging therapies for acne.
- Review established acne treatments.
- Discuss strategies to reduce acne scars.
- Discuss treatments for psoriasis and how to choose between them.
- Evaluate older and newer therapies for atopic dermatitis.
- Assess the various therapies available for acne and rosacea.
- Discuss therapeutic options for hidradenitis suppurativa.
- Discuss therapeutic options for actinic keratosis.
- Discuss the medical and surgical treatments for basal cell carcinoma.
- Discuss the medical and surgical treatments for squamous cell carcinoma.
- Discern different lesions with dermoscopy.
- Identify viral, bacterial, and fungal infections of the skin.
- Evaluate lesions and rashes in kids.
- Assess blistering disorders and treatment options.
- Discuss disorders of the hair, nails, and vulva.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form available at:
Please claim your credit by 2/15/2024.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Dermatology Research and Education Foundation. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 15.25 ANCC contact hours
Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Commercial Support
This activity is supported by an independent medical education grant from Galderma Laboratories, L.P., Incyte Corporation, Janssen Scientific Affairs, LLC, and Novartis Pharmaceuticals Corporation. This activity received in-kind support from Galderma Laboratories, L.P.
| DISCLOSURES | ||
| Name | Relationship | Commercial Interest |
| Neal Bhatia, MD (faculty) | Consultant; Grants/Research Support | AbbVie, Almirall, Arcutis, Advanced Derm Solutions, Amytrx, Beiersdorf, Biofrontera, BMS, BI, Cara Therapeutics, Castle, Dermavant, Ferndale, Foamix, Galderma, Incyte, ISDIN, J&J, La Roche-Posay, LEO, Lilly, Mindera, Novartis, Ortho, Pfizer, Procter & Gamble, Regeneron, Sanofi, Skinfix, Soligenix, SunPharma, Verrica Pharmaceuticals, Zerigo Health |
| Speaker | AbbVie, Almirall, Arcutis, Advanced Derm Solutions, Beiersdorf, Biofrontera, BMS, BI, Galderma, Incyte, ISDIN, J&J, La Roche-Posay, LEO, Lilly, Pfizer, Procter & Gamble, Regeneron, Sanofi, SunPharma, Verrica Pharmaceuticals, Zerigo Health | |
| Dawn Eichenfield, MD, PhD (faculty) | Grants/Research Support | Lilly |
| Consultant | Amyrt; Nobelpharma; Ortho Dermatologics | |
| Speaker | Beiersdorf; Regeneron/Sanofi | |
| Carolyn Goh, MD (faculty) | Consultant | Pelage; Pfizer; Sagimet |
| Speaker | Pfizer | |
| Jennifer Hsiao, MD (faculty) | Consultant | AbbVie; Aclaris; Boehringer Ingelheim; Incyte; Novartis; UCB |
| Investigator | Amgen; Boehringer Ingelheim; Incyte | |
| Speaker | AbbVie | |
| Benjamin Kelley, MD (faculty) | N/A | Nothing to disclose |
| Leon Kircik, MD (faculty) | Consultant; Investigator; Speaker | Abbott; Acambis; Aclaris; Allergan; Almirall; Amgen; Anacor; Anaptys; Astellas; Asubio; BMS; Berlex; Biogen-Idec; Biolife’ Biopelle’ Boehringer-Ingleheim; Breckenridge Pharma; Brickell; Cellceutix; Celgene; Centocor; Cipher; Coherus; Colbar; Collagenex; Combinatrix; Connetics; Coria; Dermavant; Dermik; Dermira; Dow; Dusa Pharmaceuticals; Eli Lilly; Exeltis; EOS; Ferndale; Galderma; Genentech; Glaxo-Smith Kline; HealthPoint; Idera; Intendis; Innovail; Isdin; Johnson & Johnson; 3M; Leo; L’Oreal; MC-2; Maruho; Medicis; Merc; Merz; NanoBio; Novartis; Novan; Nucryst; Obagi; Onset Therapeutics; OrthoNeutrogena; PediaPharma; Pfizer; PharmaDerm; Promius; Puracap; QLT; Quatrix; Quinnova; Serono; SkinMedica Stiefel; Sun Pharma; Taro; TolerRx; Triax Pharmaceuticals; UCB; Valeant; Warner & Chilcott; Xenoport; ZAGE |
| John Koo, MD (faculty) | Consultant; Speaker | AbbVie; Amgern; Dermavant; Janssen; Lilly; Pfizer; Regeneron/Sanofi |
| Janiene Luke, MD (faculty) | Speaker | Lilly; Regeneron/Sanofi |
| E. Victor Ross, MD (faculty) | Advisor | Agnes; Cutera; Lumenis; Lutronic; Venus Concepts |
| Consultant | Cynosure | |
| Researcher | Acclaro; Cynosure; Venus Concepts | |
| Douglas Wu, MD (faculty) | N/A | Nothing to disclose |
| Jashin Wu, MD (course director; faculty) | Consultant | AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Bausch Health, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Codex Labs, Dermavant, DermTech, Dr. Reddy’s Laboratories, Eli Lilly, EPI Health, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Samsung Bioepis, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, Zerigo Health |
| Researcher | AbbVie, Amgen, Eli Lilly, Incyte, Janssen, Novartis, Pfizer | |
| Speaker | AbbVie, Amgen, Bausch Health, EPI Health, Novartis, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, UCB | |
| Dorothy Caputo, MA, BSN, RN – VP, Healthcare Continuing Education and Operations | N/A | Nothing to disclose |
| Michele Bielarski, RN (planner/reviewer) | N/A | Nothing to disclose |
| AKH Inc Staff and Planners | N/A | Nothing to disclose |
| Dermatology Research and Education Foundation Staff and Planners | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. | ||
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.
